183 related articles for article (PubMed ID: 17228314)
21. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
[TBL] [Abstract][Full Text] [Related]
22. Effect of preexisting immunity on an adenovirus vaccine vector: in vitro neutralization assays fail to predict inhibition by antiviral antibody in vivo.
Pichla-Gollon SL; Lin SW; Hensley SE; Lasaro MO; Herkenhoff-Haut L; Drinker M; Tatsis N; Gao GP; Wilson JM; Ertl HC; Bergelson JM
J Virol; 2009 Jun; 83(11):5567-73. PubMed ID: 19279092
[TBL] [Abstract][Full Text] [Related]
23. Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.
Vitelli A; Folgori A; Scarselli E; Colloca S; Capone S; Nicosia A
Expert Rev Vaccines; 2017 Dec; 16(12):1241-1252. PubMed ID: 29047309
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
25. High-capacity adenoviral vectors circumvent the limitations of ΔE1 and ΔE1/ΔE3 adenovirus vectors to induce multispecific transgene product-directed CD8 T-cell responses.
Kron MW; Engler T; Schmidt E; Schirmbeck R; Kochanek S; Kreppel F
J Gene Med; 2011 Dec; 13(12):648-57. PubMed ID: 22095925
[TBL] [Abstract][Full Text] [Related]
26. Efficient gene delivery in human and rodent mast cells using adenovirus vectors.
Nakashima K; Sakurai F; Kawabata K; Mizuguchi H
J Control Release; 2008 Aug; 129(3):215-22. PubMed ID: 18572269
[TBL] [Abstract][Full Text] [Related]
27. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines.
Crosby CM; Nehete P; Sastry KJ; Barry MA
J Virol; 2015 Jan; 89(1):669-75. PubMed ID: 25355873
[TBL] [Abstract][Full Text] [Related]
28. The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.
Sakurai F; Murakami S; Kawabata K; Okada N; Yamamoto A; Seya T; Hayakawa T; Mizuguchi H
J Control Release; 2006 Jul; 113(3):271-8. PubMed ID: 16790289
[TBL] [Abstract][Full Text] [Related]
29. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
[TBL] [Abstract][Full Text] [Related]
30. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
[TBL] [Abstract][Full Text] [Related]
31. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
[TBL] [Abstract][Full Text] [Related]
32. The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector.
Millar J; Dissanayake D; Yang TC; Grinshtein N; Evelegh C; Wan Y; Bramson J
Cell Immunol; 2007; 250(1-2):55-67. PubMed ID: 18313652
[TBL] [Abstract][Full Text] [Related]
33. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling.
Lindsay RW; Darrah PA; Quinn KM; Wille-Reece U; Mattei LM; Iwasaki A; Kasturi SP; Pulendran B; Gall JG; Spies AG; Seder RA
J Immunol; 2010 Aug; 185(3):1513-21. PubMed ID: 20610651
[TBL] [Abstract][Full Text] [Related]
34. Langerhans cells are more efficiently transduced than dermal dendritic cells by adenovirus vectors expressing either group C or group B fibre protein: implications for mucosal vaccines.
Rozis G; de Silva S; Benlahrech A; Papagatsias T; Harris J; Gotch F; Dickson G; Patterson S
Eur J Immunol; 2005 Sep; 35(9):2617-26. PubMed ID: 16114109
[TBL] [Abstract][Full Text] [Related]
35. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
36. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1/delta E4 adenovirus vector.
Wang Q; Greenburg G; Bunch D; Farson D; Finer MH
Gene Ther; 1997 May; 4(5):393-400. PubMed ID: 9274715
[TBL] [Abstract][Full Text] [Related]
37. A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.
Peruzzi D; Dharmapuri S; Cirillo A; Bruni BE; Nicosia A; Cortese R; Colloca S; Ciliberto G; La Monica N; Aurisicchio L
Vaccine; 2009 Feb; 27(9):1293-300. PubMed ID: 19162112
[TBL] [Abstract][Full Text] [Related]
38. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.
Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG
Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039
[TBL] [Abstract][Full Text] [Related]
39. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.
Xiang Z; Li Y; Gao G; Wilson JM; Ertl HC
J Immunol; 2003 Oct; 171(8):4287-93. PubMed ID: 14530353
[TBL] [Abstract][Full Text] [Related]
40. Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Kurachi S; Tashiro K; Sugio K; Kawabata K; Yamanishi K; Mizuguchi H
Gene Ther; 2009 Aug; 16(8):1050-7. PubMed ID: 19516278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
